In 2018, the Cell Therapy Center was established in the E-Da Healthcare Group. Also we set up the GTP (Good Tissue Practice) laboratory which applies to processes of cell manufactures that meet international standards. The center aims to improve the high qualities of medical services and bring in the advanced medical technologies in order to provide the stably needs and requirements of cells for the clinical treatments and clinical trials. In the future, the technology of cell therapy will have a special place in clinical trial, research, and manufacture. Therefore, we also need to pay attention to the applicability, safety, and effectiveness of cell therapies. Because we expect to integrate medical resources, improve clinical researches and service technologies, and create a high-tech personalized medical environment, the Cell Therapy Center and GTP cell manufacture laboratory will become the important key of industry‑university‑institute alliance. In addition, we expect that the high-standard production of cell therapy products will be officially approved in Taiwan and get into the international market.

(1) To follow the GTP regulations for planning and control;
(2) To make the procedures of cell production to meet the high specification for international standards;
(3) To obtain the certification of ISO 17025 for quality control inspections of cells and reagents.